A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
Clinical trial NCT05979831 · TERMINATED
Trial details
- NCT number
- NCT05979831
- Sponsor
- Daiichi Sankyo
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2025-01-06
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.